Visual assessment of [11C]PIB PET in patients with cognitive impairment

被引:27
|
作者
Suotunen, Timo [1 ]
Hirvonen, Jussi [1 ]
Immonen-Raiha, Pirjo [2 ]
Aalto, Sargo [1 ,3 ]
Lisinen, Irina [4 ]
Arponen, Eveliina [1 ]
Teras, Mika [1 ]
Koski, Kari [5 ]
Sulkava, Raimo [6 ,7 ]
Seppanen, Marko [1 ]
Rinne, Juha O. [1 ,2 ]
机构
[1] Turku PET Ctr, Turku 20521, Finland
[2] Turku Univ Hosp, FIN-20520 Turku, Finland
[3] Abo Akad Univ, Dept Psychol, Turku, Finland
[4] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland
[5] Salo Reg Hosp, Neurol Outpatient Dept, Salo, Finland
[6] Univ Kuopio, Sch Publ Hlth & Clin Nutr, Geriatr Unit, Kuopio, Finland
[7] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
基金
芬兰科学院;
关键词
Alzheimer's disease; PET; C-11-PIB; C-11-6-OH-BTA-1; Visual assessment; Amyloid imaging; VOXEL-BASED ANALYSIS; AMYLOID LIGAND; ALZHEIMERS-DISEASE; ATROPHY; HIPPOCAMPAL; DEPOSITION; F-18-FDG; DEMENTIA; BURDEN; MRI;
D O I
10.1007/s00259-010-1382-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to evaluate the visual assessment of positron emission tomography images of N-[methyl-11C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole ([11C]PIB) in a patient population with mild to moderate memory impairment or dementia. We compared the visual ratings of two readers using kappa statistics and correlated the results of visual and quantitative region of interest (ROI) analyses. The one reader had good experience in evaluating PIB images and the other had little previous experience. The sensitivity and specificity of the visual assessment was determined using quantitative data from 18 healthy controls previously examined: [11C]PIB uptake was considered as abnormal if it was more than 2 SD above the mean of the healthy subjects. The evaluation of visual classification as "normal" or "abnormal" showed good interobserver agreement (kappa = 0.90). There was a clear correlation between visual and quantitative analysis (r = 0.47-0.79, p < 0.001). The most difficult visually assessed brain area was the putamen (kappa = 0.11; correlation with quantitative analysis: reader A r = 0.22; reader B r = 0.60). Our study shows that visual evaluation of [C-11]PIB images conforms with quantitative analyses also in a clinical patient population supporting the feasibility of visual evaluation in clinical settings.
引用
收藏
页码:1141 / 1147
页数:7
相关论文
共 50 条
  • [1] Visual assessment of [11C]PIB PET in patients with cognitive impairment
    Timo Suotunen
    Jussi Hirvonen
    Pirjo Immonen-Räihä
    Sargo Aalto
    Irina Lisinen
    Eveliina Arponen
    Mika Teräs
    Kari Koski
    Raimo Sulkava
    Marko Seppänen
    Juha O. Rinne
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1141 - 1147
  • [2] 11C-PIB PET in subjective cognitive impairment
    Rodda, J.
    Okello, A.
    Edison, P.
    Dannhauser, T.
    Brooks, D. J.
    Walker, Z.
    EUROPEAN PSYCHIATRY, 2010, 25 (02) : 123 - 125
  • [3] [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
    Bruck, A.
    Virta, J. R.
    Koivunen, J.
    Koikkalainen, J.
    Scheinin, N. M.
    Helenius, H.
    Nagren, K.
    Helin, S.
    Parkkola, R.
    Viitanen, M.
    Rinne, J. O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (10) : 1567 - 1572
  • [4] A 5-year longitudinal evaluation in patients with mild cognitive impairment by 11C-PIB PET/CT: a visual analysis
    Jimenez-Bonilla, Julio F.
    Quirce, Remedios
    De Arcocha-Torres, Maria
    Martinez-Rodriguez, Isabel
    Martinez-Amador, Nestor
    Sanchez-Salmon, Aida
    De la Fuente-Gomez, Francisco
    Rodriguez, Eloy
    Sanchez-Juan, Pascual
    Banzo, Ignacio
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (05) : 525 - 531
  • [5] Patterns of 11C-PIB cerebral retention in mild cognitive impairment patients
    Banzo, I.
    Jimenez-Bonilla, J. F.
    Martinez-Rodriguez, I.
    Quirce, R.
    de Arcocha-Torres, M.
    Bravo-Ferrer, Z.
    Lavado-Perez, C.
    Sanchez-Juan, P.
    Rodriguez, E.
    Jimenez-Alonso, M.
    Lopez-Defillo, J.
    Carril, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2016, 35 (03): : 171 - 174
  • [6] [11C]PIB-, [18F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia
    Jokinen, Pekka
    Scheinin, Noora
    Aalto, Sargo
    Nagren, Kjell
    Savisto, Nina
    Parkkola, Riitta
    Rokka, Johanna
    Haaparanta, Merja
    Roytta, Matias
    Rinne, Juha O.
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (10) : 666 - 670
  • [7] PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment
    Koivunen, J.
    Pirttilae, T.
    Kemppainen, N.
    Aalto, S.
    Herukka, S. -K.
    Jauhianen, A. M.
    Haenninen, T.
    Hallikainen, M.
    Nagren, K.
    Rinne, J. O.
    Soininen, H.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 26 (04) : 378 - 383
  • [8] Noninvasive Measurement of [11C]PiB Distribution Volume Using Integrated PET/MRI
    Okazawa, Hidehiko
    Ikawa, Masamichi
    Tsujikawa, Tetsuya
    Makino, Akira
    Mori, Tetsuya
    Kiyono, Yasushi
    Kosaka, Hirotaka
    DIAGNOSTICS, 2020, 10 (12)
  • [9] Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease
    Leuzy, Antoine
    Carter, Stephen F.
    Chiotis, Konstantinos
    Almkvist, Ove
    Wall, Anders
    Nordberg, Agneta
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 45 (04) : 1077 - 1088
  • [10] Amyloid Pet imaging with 11C-PIB in two patients with cognitive impairment
    Ortega-Nava, F.
    Martinez-Rodriguez, I.
    De Arcocha-Torres, M.
    Rodriguez, E.
    Mateo, I.
    Carril, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2012, 31 (01): : 40 - 41